Company / Income Tax
NEKTAR THERAPEUTICS Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
-$138.0K
FY2025
5-year range
-$200.0K / $3.2M
FY2021-FY2025
Trend
+31.0%
vs FY2024
Sector context
#175 of 204
Health Care
What the data says
NEKTAR THERAPEUTICS's income tax of -$138,000 is lower than 86% of companies in the Health Care sector (FY2025). Income Tax returned to growth in FY2025 after 2 years of decline, reaching -$138,000.
Based on SEC 10-K filings.
-$138,000 in FY2025.
Improved from $557,000 to -$138,000 over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 204This company -$138.0K Sector average $118.7M
▼
-100.1% below sector average
Key checks
Key Insights
- In FY2025, income tax increased 31.0% year-over-year.
- Ranks #175 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2022.
- Lowest income tax in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -11.97 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$138.0K | +31.0% |
| FY2024 | -$200.0K | -135.9% |
| FY2023 | $557.0K | -82.7% |
| FY2022 | $3.2M | +477.2% |
| FY2021 | $557.0K | -60.6% |
| FY2020 | $1.4M | +129.2% |
| FY2019 | $616.0K | -29.7% |
| FY2018 | $876.0K | +42.2% |
| FY2017 | $616.0K | +220.3% |
| FY2016 | -$512.0K | -201.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026